Article
Source: Campus Sanofi

ORION Observational Study

Author : Sanofi

Editorial Team

All relevant safety information about adverse reactions, precautions, and relevant contraindications can be found on the product page HERE.

There is an intense desire to participate in fasting during Ramadan, even among the people who could seek exemption. Discover the ORION study.

The ORION observational study

Real-world safety and effectiveness of Toujeo® (insulin glargine 300 U/mL) in people with T2DM who fast during Ramadan

Read Study

See More From Science

Toujeo® (insulin glargine 300 units/ml)

Toujeo^® is indicated as treatment of diabetes mellitus in adults, adolescents and children from the age of 6 years.

Patient Materials

Find resources and support for your patients who have been prescribed Toujeo^®. This section will help you to help your patients understand the basis of living and staying well with diabetes and how to have a a positive start and experience with Toujeo^®.